Skip to main content
. 2015 Sep 1;2015:765292. doi: 10.1155/2015/765292

Table 1.

Right heart hemodynamics at 4 weeks.

Group
(n)
RNU_M
(8)
RNU_F
(8)
SU_M
(8)
SU_F
(11)
Semaxanib (mg/kg) 0 0 40 40
Heart rate (beat/min) 269 ± 37 311 ± 35 296 ± 48 280 ± 73
RVESP (mm Hg) 21 ± 2.5 24.3 ± 8.1 66.3 ± 8.9 29.5 ± 13.4
RVEDP (mm Hg) 1.5 ± 3.5 3 ± 3.6 6.2 ± 2.8§ 2.1 ± 4.3
CO (mL/min) 134 ± 4 122 ± 5 58 ± 24 89 ± 17
PVR (dyn·s·cm−5) 0.013 ± 0.002 0.016 ± 0.006 0.103 ± 0.06 0.027 ± 0.01
dP/dt max (mm Hg/s) 1173 ± 161 1311 ± 414 2636 ± 495 1374 ± 320
dP/dt min (mm Hg/s) −1318 ± 37 −871 ± 232 −2370 ± 912 −1072 ± 415
E es (mm Hg/µL) 0.19 ± 0.05 0.21 ± 0.15 0.12 ± 0.06 0.18 ± 0.05
E a (mm Hg/µL) 0.04 ± 0.01 0.06 ± 0.03 0.33 ± 0.12 0.09 ± 0.02
E es/E a 4.75 ± 0.63 3.5 ± 0.45 0.36 ± 0.17 2.1 ± 0.34

RVESP: right ventricular end-systolic pressure; RVEDP: right ventricular end-diastolic pressure; CO: cardiac output; PVR: pulmonary vascular resistance; dP/dt max: right ventricular maximal isovolumic rate of development of ventricular pressure; dP/dt min: right ventricular minimal isovolumic rate of development of ventricular pressure. Other abbreviations are in text. explains P < 0.05 for comparison with SU_F; # explains P < 0.05 for comparison with RNU_M; § explains P < 0.05 for comparison with RNU_F.